Nitric oxide in shock.

Area of Science:

• Cardiovascular Physiology
• Shock Pathophysiology
• Pharmacology

Background:

• Distributive shock, including septic and anaphylactic shock, is characterized by refractory hypotension and end-organ hypoperfusion.
• Nitric oxide (NO), identified as endothelium-derived relaxing factor, significantly influences vascular tone.
• The role of NO in shock has been extensively studied, revealing complex and context-dependent effects.

Purpose of the Study:

• To review the contribution of NO to the pathophysiology of septic and anaphylactic shock.
• To evaluate the therapeutic potential of nitric oxide synthase (NOS) inhibition in managing these conditions.
• To explore alternative treatment strategies for septic shock beyond NOS inhibition.

Main Methods:

• Literature review of studies investigating NO production and its effects in septic and anaphylactic shock models.
• Analysis of clinical trial data, including a failed Phase III trial for septic shock treatment.
• Examination of the specific roles of different nitric oxide synthase (NOS) isoforms (iNOS and eNOS) in shock.

Main Results:

• NOS inhibition restores blood pressure in shock but does not improve patient outcomes in septic shock.
• In anaphylactic shock, NO produced by endothelial NOS (eNOS), not inducible NOS (iNOS), mediates the shock response.
• Selective iNOS inhibitors are being investigated for septic shock, but downstream cardiovascular targets of NO may also be crucial.

Conclusions:

• NOS inhibition shows promise for anaphylactic shock, but alternative strategies are needed for septic shock.
• The dual role of NO as both protective and detrimental in shock necessitates targeted therapeutic approaches.
• Future research should consider targeting downstream cardiovascular effects of NO or other vasodilatory mechanisms for effective shock management.